(Q40041063)

16 September 2017

Dyslipidemia and Diabetes Increase the OPG/TRAIL Ratio in the Cardiovascular System (English)

1 reference

16 September 2017

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28070143%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Barbara Toffoli

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28070143%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

author name string

Bruno Fabris

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28070143%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Giacomo Bartelloni

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28070143%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Fleur Bossi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28070143%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

publication date

14 December 2016

1 reference

Mediators of Inflammation

16 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28070143%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

volume

2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28070143%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

page(s)

6529728

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28070143%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

9 June 2020

copyright license

start time

1 January 2016

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Roles and Clinical Applications of OPG and TRAIL as Biomarkers in Cardiovascular Disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5192341

Targeting the extrinsic apoptotic pathway in cancer: lessons learned and future directions

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5192341

Role of osteoprotegerin and its gene polymorphisms in the occurrence of left ventricular hypertrophy in essential hypertensive patients

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5192341

Intranasal administration of recombinant TRAIL down-regulates CXCL-1/KC in an ovalbumin-induced airway inflammation murine model

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5192341

Lifetime risks of cardiovascular disease

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5192341

Oxidized lipids enhance RANKL production by T lymphocytes: implications for lipid-induced bone loss

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5192341

Osteoprotegerin and soluble receptor activator of nuclear factor-kappaB ligand and risk for coronary events: a nested case-control approach in the prospective EPIC-Norfolk population study 1993-2003.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5192341

Potential prognostic significance of decreased serum levels of TRAIL after acute myocardial infarction

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5192341

An increased osteoprotegerin serum release characterizes the early onset of diabetes mellitus and may contribute to endothelial cell dysfunction

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5192341

Lipoprotein lipase (LpL) on the surface of cardiomyocytes increases lipid uptake and produces a cardiomyopathy

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5192341

Dyslipidemia and an unfavorable fatty acid profile predict left ventricular hypertrophy 20 years later

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5192341

Hypertension and endothelial dysfunction in apolipoprotein E knockout mice

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5192341

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5192341

Resolved and unresolved issues in the prevention and treatment of coronary artery disease: a workshop consensus statement

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5192341

TRAIL attenuates the development of atherosclerosis in apolipoprotein E deficient mice

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5192341

Left ventricular geometry and arterial function in hypercholesterolemia

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5192341

ACE2 deficiency shifts energy metabolism towards glucose utilization.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5192341

Osteoprotegerin increases in metabolic syndrome and promotes adipose tissue proinflammatory changes.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5192341

Oxidized low density lipoprotein increases RANKL level in human vascular cells. Involvement of oxidative stress

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5192341

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5192341

Osteoprotegerin promotes vascular fibrosis via a TGF-β1 autocrine loop

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5192341

Human full-length osteoprotegerin induces the proliferation of rodent vascular smooth muscle cells both in vitro and in vivo

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5192341

The involvement of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in atherosclerosis.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5192341

Transgenic expression of fatty acid transport protein 1 in the heart causes lipotoxic cardiomyopathy

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5192341

Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5192341

An imbalanced OPG/TRAIL ratio is associated to severe acute myocardial infarction

20 August 2018

1 reference

https://api.crossref.org/works/10.1155%2F2016%2F6529728

Osteoprotegerin induces morphological and functional alterations in mouse pancreatic islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2016%2F6529728

TRAIL shows potential cardioprotective activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2016%2F6529728

Osteoprotegerin increases leukocyte adhesion to endothelial cells both in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2016%2F6529728

Systemic Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Delivery Shows Antiatherosclerotic Activity in Apolipoprotein E–Null Diabetic Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2016%2F6529728

Dysregulated osteoprotegerin/RANK ligand/RANK axis in clinical and experimental heart failure

21 January 2018

1 reference

12 December 2020

Osteoprotegerin: a biomarker with many faces

1 reference

12 December 2020

Increased OPG expression and impaired OPG/TRAIL ratio in the aorta of diabetic rats

1 reference

12 December 2020

Localization of osteoprotegerin, tumor necrosis factor-related apoptosis-inducing ligand, and receptor activator of nuclear factor-kappaB ligand in Mönckeberg's sclerosis and atherosclerosis

1 reference

12 December 2020

Expression of proto-oncogenes and gene mutation of sarcomeric proteins in patients with hypertrophic cardiomyopathy

1 reference

12 December 2020

1 reference

12 December 2020

Identifiers

DOI

10.1155/2016/6529728

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28070143%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28070143%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

PubMed publication ID

28070143

1 reference